This free, online training will focus on buprenorphine treatment of opioid use disorder in an office-based setting. The standard Provider Clinical Support System (PCSS) will be presented and will qualify for the first half of training to receive the DATA 2000 buprenorphine waiver. 4 free CME available for physicians, as well as CE for nurses, pharmacists, and physician assistants. Interprofessional CE credits also avaiilable.
Date: March 4, 2022
Time: 12:30 - 5:00 p.m.
→ Program flyer (PDF)
- Describe the components of evaluation for medication assisted treatment
- Discuss the range of treatment goals for patients with Opioid Use Disorder (OUD)
- Identify the FDA-approved pharmacological treatments for OUD
- Demonstrate an understanding of the benefits, limitations and differences of available treatments
- Describe different first and second-line approaches to treat OUD and processes of shared decision making
This training offers a portion of required hours. It uses the Half-and-Half format, in which 4.25-hours is virtual training is followed by 3.75 hours of home computer-based self-study. Participants are not required to prescribe buprenorphine after taking this training, nor are they required to be listed as buprenorphine prescribers on any database.
Dr. Daniel Warren is the Medical Director at Wichita Treatment Center and also prescribes buprenorphine for opioid use disorder at HealthCore Clinic in Wichita. Dr. Warren graduated from medical school at the University of Kansas. He completed family medicine residency training at Naval Hospital Bremerton while serving in the US Navy. He then graduated fellowship training in addiction medicine at Oregon Health and Science University. He is currently working at University of Kansas School of Medicine-Wichita to develop a community response to substance use, primarily by developing skills and training in the primary care workforce.
This course is being sponsored by Johnson County Department of Health and Environment, Johnson County Mental Health Center.
This workshop has been funded by a grant from the Kansas Department of Health and Environment through the Centers for Disease Control and Prevention under Federal Award Identification Number 1 NU90TP921961-01-00.